Omicron Covid19 (B.1.1.529) | ||||
المجلة العربية للعلوم الزراعية | ||||
Article 4, Volume 5, Issue 13, January 2022, Page 49-54 PDF (1.03 MB) | ||||
DOI: 10.21608/asajs.2022.212781 | ||||
View on SCiNiTO | ||||
Author | ||||
Ashraf Mohamed Abbas | ||||
Scientific Molecular biology consultant Magazine members Head of Genetic Engineering Research Department (GERD), VSVRI, ARC, Egypt | ||||
Abstract | ||||
On November 23rd, scientists in South Africa alerted the world to a new variant of SARS-CoV-2, the virus that causes COVID-19. Officially named the B.1.1.529 variant, it has been designated Omicron as part of the World Health Organization (WHO)’s Greek naming system, and has put health officials and researchers around the world on high alert as they make sense of its potential implications for the ongoing global pandemic. In addition to South Africa, the new variant has been detected in at least 15 countries in Africa, Europe, and North America, according to CNN, prompting myriad restrictions on international travel. The variant is likely already present in additional countries, including the United States, The Wall Street Journal reports | ||||
References | ||||
[3] https://www.bbc.com/news/health-59520945. The new Covid -19 variant :B.1.1.529. [4] Wang, R., X. Luo, F. Liu and S. Luo (2021). "Confronting the threat of SARS-CoV-2: Realities, challenges and therapeutic strategies." Experimental and Therapeutic Medicine 21(2): 1-1. [5] https://www.eurekalert.org/multimedia/680769). Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. [6] Li, Q., J. Nie, J. Wu, L. Zhang, R. Ding, H. Wang, Y. Zhang, T. Li, S. Liu and M. Zhang (2021). "SARS-CoV-2 501Y. V2 variants lack higher infectivity but do have immune escape." Cell 184(9): 2362-2371. e2369. [7]https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern
| ||||
Statistics Article View: 180 PDF Download: 149 |
||||